Vir Biotechnology, Inc.
VIR
$9.26
-$0.22-2.32%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 73.69% | -47.03% | 8.27% | -15.66% | 51.06% |
| Total Depreciation and Amortization | -3.34% | 2.78% | 1.74% | -0.66% | -0.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 28.99% | 2.26% | -7.47% | -55.19% | 42.21% |
| Change in Net Operating Assets | 86.19% | 17.80% | -196.17% | 253.28% | -197.19% |
| Cash from Operations | 84.56% | -39.39% | -53.90% | 10.86% | 48.89% |
| Capital Expenditure | -9.78% | 87.51% | -55.80% | 18.35% | 27.93% |
| Sale of Property, Plant, and Equipment | -397.30% | -17.78% | -83.99% | -88.55% | 49,000.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 113.89% | -30.91% | -54.01% | -8.63% | 15.58% |
| Cash from Investing | 114.24% | -28.36% | -55.48% | -9.89% | 18.66% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 930.69% | -95.80% | 302.34% | -52.16% | 1,660.56% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -300.00% | 100.28% | -- | -- | 132.50% |
| Cash from Financing | 918.63% | -95.01% | 242.14% | -52.65% | 3,974.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 148.66% | -105.81% | -225.19% | -9.32% | 202.87% |